331
Participants
Start Date
November 23, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Sacituzumab Govitecan-hziy
Sacituzumab govitecan 10 mg/kg via IV injection administered on Days 1 and 8 of a 21-day cycle. Subjects will continue to receive study treatment until PD as judged by local investigator review, development of unacceptable toxicity, or withdrawal of consent.
Eribulin Mesylate Injection
Eribulin is administered by intravenous (IV) following recommended doses and regimens as per approved package inserts.
Capecitabine Oral Product
Capecitabine is administered orally (PO) following recommended doses and regimens as per approved package inserts.
Gemcitabine Injection
Gemcitabine is administered by intravenous (IV) following recommended doses and regimens as per approved package inserts.
Vinorelbine injection
Vinorelbine is administered by intravenous (IV) following recommended doses and regimens as per approved package inserts.
Cancer Hospital Chinese Academy of Medical Science, Beijing
Chinese PLA General Hospital, Beijing
Peking University People's Hospital, Beijing
Jilin Cancer Hospital, Changchun
The First Hospital of Jilin University, Changchun
Chongqing University Cancer Hospital, Chengdu
West China Hospital, Sichuan University, Chengdu
Fujian Medical University Union Hospital, Fuzhou
Guangdong Provincial People's Hospital, Guangzhou
Sun Yat Sen Memorial Hospital of Sun Yat sen University, Guangzhou
Sun Yat-sen University Cancer Center, Guangzhou
Sir Run run Shaw hospital Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Anhui Provincial Hospital, Hefei
The second Hospital of Anhui Medical University, Hefei
Shandong Cancer Hospital, Jinan
Yunnan Cancer Hospital, Kunming
Linyi Cancer Hospital, Linyi
Jiangsu Province Hospital, Nanjing
Nanjing Drum Tower Hospital, Nanjing
Shanghai General Hospital, Shanghai
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Affiliated Tumor Hospital of Xinjiang Medical University, Ürümqi
Hubei Cancer Hospital, Wuhan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Henan Cancer Hospital, Zhengzhou
Dong-A University Hospital, Busan
Seoul National University Bundang Hospital, Seongnam
Asan Medical Center, Seoul
Korea University Anam Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Ajou University Hospital, Suwon
Changhua Christian Medical Foundation Changhua Christian Hospital, Changhua
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
China Medical University Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Tri-Service General Hospital, Taipei
Chang Gung Memorial Hospital, Linkou, Taoyuan District
Lead Sponsor
Gilead Sciences
INDUSTRY